Ponte JF - Search Results

1

Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder.

Abdolmaleky HM, Cheng KH, Faraone SV, Wilcox M, Glatt SJ, Gao F, Smith CL, Shafa R, Aeali B, Carnevale J, Pan H, Papageorgis P, Ponte JF, Sivaraman V, Tsuang MT, Thiagalingam S. Abdolmaleky HM, et al. Among authors: ponte jf. Hum Mol Genet. 2006 Nov 1;15(21):3132-45. doi: 10.1093/hmg/ddl253. Epub 2006 Sep 19. Hum Mol Genet. 2006. PMID: 16984965 Free PMC article.

2

Elucidation of epigenetic inactivation of SMAD8 in cancer using targeted expressed gene display.

Cheng KH, Ponte JF, Thiagalingam S. Cheng KH, et al. Among authors: ponte jf. Cancer Res. 2004 Mar 1;64(5):1639-46. doi: 10.1158/0008-5472.can-03-2688. Cancer Res. 2004. PMID: 14996722

3

Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer.

Pan H, Califano J, Ponte JF, Russo AL, Cheng KH, Thiagalingam A, Nemani P, Sidransky D, Thiagalingam S. Pan H, et al. Among authors: ponte jf. Cancer Res. 2005 Mar 1;65(5):1664-9. doi: 10.1158/0008-5472.CAN-04-3297. Cancer Res. 2005. PMID: 15753360

4

Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer.

Russo AL, Thiagalingam A, Pan H, Califano J, Cheng KH, Ponte JF, Chinnappan D, Nemani P, Sidransky D, Thiagalingam S. Russo AL, et al. Among authors: ponte jf. Clin Cancer Res. 2005 Apr 1;11(7):2466-70. doi: 10.1158/1078-0432.CCR-04-1962. Clin Cancer Res. 2005. PMID: 15814621

5

hBub1 deficiency triggers a novel p53 mediated early apoptotic checkpoint pathway in mitotic spindle damaged cells.

Gao F, Ponte JF, Papageorgis P, Levy M, Ozturk S, Lambert AW, Pan H, Chinnappan D, Cheng KH, Thiagalingam A, Abdolmaleky HM, Thiagalingam S. Gao F, et al. Among authors: ponte jf. Cancer Biol Ther. 2009 Apr;8(7):627-35. doi: 10.4161/cbt.8.7.7928. Epub 2009 Apr 22. Cancer Biol Ther. 2009. PMID: 19242126

6

hBub1 negatively regulates p53 mediated early cell death upon mitotic checkpoint activation.

Gao F, Ponte JF, Levy M, Papageorgis P, Cook NM, Ozturk S, Lambert AW, Thiagalingam A, Abdolmaleky HM, Sullivan BA, Thiagalingam S. Gao F, et al. Among authors: ponte jf. Cancer Biol Ther. 2009 Apr;8(7):548-56. Epub 2009 Apr 22. Cancer Biol Ther. 2009. PMID: 19252416

7

Histone deacetylases: unique players in shaping the epigenetic histone code.

Thiagalingam S, Cheng KH, Lee HJ, Mineva N, Thiagalingam A, Ponte JF. Thiagalingam S, et al. Among authors: ponte jf. Ann N Y Acad Sci. 2003 Mar;983:84-100. doi: 10.1111/j.1749-6632.2003.tb05964.x. Ann N Y Acad Sci. 2003. PMID: 12724214 Review.

8

Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence.

Thiagalingam S, Foy RL, Cheng KH, Lee HJ, Thiagalingam A, Ponte JF. Thiagalingam S, et al. Among authors: ponte jf. Curr Opin Oncol. 2002 Jan;14(1):65-72. doi: 10.1097/00001622-200201000-00012. Curr Opin Oncol. 2002. PMID: 11790983 Review.

9

Phase 1 dose-escalation study of mirvetuximab soravtansine (IMGN853), a folate receptor α-targeting antibody-drug conjugate, in patients with solid tumors.

Moore KN, Borghaei H, O'Malley DM, Jeong W, Seward SM, Bauer TM, Perez RP, Matulonis UA, Running KL, Zhang X, Ponte JF, Ruiz-Soto R, Birrer MJ. Moore KN, et al. Among authors: ponte jf. Cancer. 2017 Aug 15;123(16):3080-3087. doi: 10.1002/cncr.30736. Epub 2017 Apr 25. Cancer. 2017. PMID: 28440955 Free PMC article. Clinical Trial.

10

A DNA-Interacting Payload Designed to Eliminate Cross-Linking Improves the Therapeutic Index of Antibody-Drug Conjugates (ADCs).

Miller ML, Shizuka M, Wilhelm A, Salomon P, Reid EE, Lanieri L, Sikka S, Maloney EK, Harvey L, Qiu Q, Archer KE, Bai C, Vitharana D, Harris L, Singh R, Ponte JF, Yoder NC, Kovtun Y, Lai KC, Ab O, Pinkas J, Keating TA, Chari RVJ. Miller ML, et al. Among authors: ponte jf. Mol Cancer Ther. 2018 Mar;17(3):650-660. doi: 10.1158/1535-7163.MCT-17-0940. Epub 2018 Feb 13. Mol Cancer Ther. 2018. PMID: 29440292

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page